PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS- CURRENT KNOWLEDGE AND RECENT ADVANCES: MINI REVIEW-Reference-Cited by-同舟云学术

PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS- CURRENT KNOWLEDGE AND RECENT ADVANCES: MINI REVIEW

Published:2021-05-01 Issue: Volume: Page:4-6
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Sinha Abhishek¹,Loganathan Sundareswaran²,S Krishnan²,Mahanta Anindita²,P Naveen³,Bhattacharjee Manasi⁴

Affiliation:

1. Associate Professor, Department of Physiology, All India Institute of Medical Sciences, Guwahati

2. Assistant Professor, Department of Physiology, All India Institute of Medical Sciences, Guwahati.

3. Additional Professor, Department of Physiology, All India Institute of Medical Sciences, Guwahati.

4. Professor, Department of Physiology, All India Institute of Medical Sciences, Guwahati.

Abstract

Diabetes Mellitus is a very common disease prevalent all across the world including the Indian subcontinent. With over 69 million people with Type 2 DM, India has the second highest number of people living with diabetes mellitus worldwide. Considering the current scenario, understanding newer aspects of the pathophysiology of Diabetes Mellitus is of prime signicance as it will help in development of better treatment modalities especially drug therapies and crucial lifestyle modications . The aim of this mini review is to discuss newer advances in our understanding of pathophysiology of Diabetes Mellitus beyond the available textbook information. As Type 2 DM is the predominant form of disease worldwide, we will be discussing its pathophysiology in this review. The complex facts regarding the pathophysiology of Type 2 DM have been presented in a simple manner to make it easier to read and comprehend

Publisher

World Wide Journals

Reference26 articles.

1. International Diabetes Federation. IDF Diabetes Atlas Update Poster.6th ed. Brussels, Belgium: International Diabetes Federation;2017.

2. American Diabetes Association. Economic costs of diabetes in the U.S.in 2017.Diabetes Care.2018;41(5):917-928.

3. Williams Endocrinology.14th edition. Elsevier. Pg 13501-51.

4. DeFronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm to the treatment of type 2 diabetes mellitus. Diabetes.2009;58(4):773-795.

5. DeFronzo RA.The triumvirate : beta cell, muscle , liver- a collusion responsible for NIDDM. Lilly lecture 1987.Diabetes.1988;37:667-687.